🔍

NEOGEN - Neogen Chemicals

📊 NSE: NEOGEN 🏢 Chemicals 📅 Last Updated: 12/14/2025 10:27

📢 Recent Corporate Announcements

Neogen Chemicals Subsidiary to Invest ₹100.11 Cr in Step-Down Subsidiary for EV Battery Materials

🟢 POSITIVE ⭐ 7/10

EXPANSION 📅 28 Apr 2026, 06:37 PM

Neogen Chemicals' wholly-owned subsidiary, Neogen Ionics Limited (NIL), has approved an investment of ₹100.11 crore in its step-down subsidiary, Neogen Morita New Material Limited (NML). The investment will be executed through a rights issue of 71,00,000 equity shares at a price of ₹141 per share. This capital infusion is specifically targeted at the Lithium-Ion Battery material space, focusing on electrolyte salts for both internal consumption and global markets. The move signifies Neogen's aggressive expansion into the electric vehicle supply chain ecosystem.

Investment of ₹100.11 crore via rights issue in step-down subsidiary Neogen Morita New Material Limited (NML).
Subscription of 71,00,000 equity shares at ₹141 per share (including a premium of ₹131).
NML's authorized share capital increased from ₹5 crore to ₹9.9 crore to accommodate the issuance.
Funds earmarked for acquiring salt business, CAPEX, and OPEX requirements for Lithium-Ion Battery materials.
The transaction is expected to be completed within 60 days of receipt of share application money.

💡 Investors should monitor the progress of the Lithium-Ion Battery material project as it represents a high-growth vertical for the company. While the investment is strategic, the long-term impact will depend on the successful execution of CAPEX and market adoption of their electrolyte salts.

Neogen Chemicals Launches Saksham Niveshak Campaign for Unclaimed Dividends (FY19-FY25)

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 28 Apr 2026, 05:10 PM

Neogen Chemicals has initiated the 'Saksham Niveshak' campaign, running from April 1 to July 9, 2026, following directives from the IEPFA. The campaign aims to assist shareholders in claiming unpaid or unclaimed dividends for the financial years 2018-19 through 2024-25. Shareholders are urged to update their KYC, PAN, and bank mandate details to facilitate direct electronic transfers and prevent the transfer of these funds to the Investor Education and Protection Fund (IEPF).

Campaign runs for 100 days from April 1, 2026, to July 9, 2026.
Covers unclaimed dividends for seven financial years from 2018-19 to 2024-25.
Physical shareholders must submit forms ISR-1, ISR-2, and SH-13/14 to the RTA, MUFG Intime India.
Demat shareholders must update KYC and bank details with their respective Depository Participants (DP).
Unclaimed dividends not processed will eventually be transferred to the IEPF Authority as per statutory requirements.

💡 Shareholders should check the 'Unclaimed/Unpaid Dividend' section on Neogen's website and ensure their bank mandates and KYC are updated to receive any pending funds.

Neogen Chemicals Allots 10 Lakh Shares to Promoter Group for Rs 161 Crore

🟢 POSITIVE ⭐ 7/10

FUNDRAISE 📅 20 Apr 2026, 06:49 PM

Neogen Chemicals has completed a preferential allotment of 10,00,000 equity shares to Cadamba Solutions Private Limited, a member of the promoter group. The allotment was executed at a price of Rs. 1,610 per share (including a premium of Rs. 1,600), resulting in a total capital infusion of Rs. 161 crore. This transaction increases the promoter group's holding, with this specific entity now owning 3.65% of the post-allotment paid-up capital. Such a significant investment by promoters at a premium is generally viewed as a strong signal of confidence in the company's future growth.

Allotment of 10,00,000 equity shares at an issue price of Rs. 1,610 per share
Total investment amount aggregates to Rs. 161 crore for cash consideration
Acquisition constitutes 3.65% of the post-allotment paid-up equity capital
Total paid-up equity capital increased from Rs. 26.38 crore to Rs. 27.38 crore
The acquirer, Cadamba Solutions Private Limited, belongs to the promoter group

💡 Investors should take this as a positive indicator of promoter commitment and confidence in the company's valuation. Monitor the company's upcoming quarterly results to see how this additional capital is deployed for expansion.

Neogen Chemicals Promoter Group Acquires 10 Lakh Shares via Preferential Allotment for ₹161 Cr

🟢 POSITIVE ⭐ 7/10

FUNDRAISE 📅 20 Apr 2026, 06:47 PM

Neogen Chemicals has successfully completed a preferential allotment of 10,00,000 equity shares to Cadamba Solutions Private Limited, a member of the promoter group. The shares were issued at a price of ₹1,610 per share, resulting in a total capital infusion of ₹161 crores into the company. This transaction gives the promoter group entity a 3.65% stake in the expanded post-allotment equity capital. Such significant investment by the promoter group is generally viewed as a strong signal of confidence in the company's valuation and future growth prospects.

Allotment of 10,00,000 equity shares at an issue price of ₹1,610 per share
Total capital infusion of ₹161 crores by promoter group entity Cadamba Solutions
Acquirer's stake represents 3.65% of the post-allotment paid-up equity capital
Total paid-up equity capital increased from ₹26.38 crore to ₹27.38 crore
The allotment was finalized on April 18, 2026, following regulatory compliance

💡 Investors should take note of the promoter group's commitment at the ₹1,610 price point, which serves as a positive valuation benchmark. The capital infusion strengthens the balance sheet and supports future expansion plans.

Neogen Chemicals Promoter Discloses Pledge of 13.19 Lakh Equity Shares

🔵 WATCH ⭐ 6/10

REGULATORY 📅 09 Apr 2026, 03:33 PM

Dr. Harin Kanani, representing the Haridas Kanani Family Trust, has submitted a mandatory annual declaration under SEBI Takeover Regulations for the financial year ended March 31, 2026. The disclosure confirms that the promoter group maintained its shares without encumbrance for most of the year, except for a specific pledge. On March 30, 2026, a pledge was created on 13,19,083 equity shares held by Dr. Harin Kanani. This filing ensures transparency regarding promoter shareholding and any potential liens on their stake.

Pledge created on 13,19,083 equity shares of Neogen Chemicals Limited
Encumbrance was established by Dr. Harin Kanani on March 30, 2026
Declaration filed under Regulation 31(4) of SEBI (SAST) Regulations, 2011
No other creation, invocation, or release of encumbrance occurred during FY 2025-26

💡 Investors should monitor the total percentage of promoter equity now pledged to assess any potential risk of margin calls. While pledging is a common financing tool, a significant increase in encumbered shares can impact market sentiment.

Neogen Chemicals Promoter Dr. Harin Haridas Kanani Pledges 13.19 Lakh Shares

🔵 WATCH ⭐ 6/10

REGULATORY 📅 08 Apr 2026, 06:45 PM

Dr. Harin Haridas Kanani, a promoter of Neogen Chemicals Limited, has disclosed the creation of a pledge on 13,19,083 equity shares as of March 30, 2026. This disclosure, made under SEBI (SAST) Regulations, confirms that this was the only encumbrance activity by the promoter group during the financial year ended March 31, 2026. While pledging is a common financial tool, it is closely watched by investors as it involves using company ownership as collateral. The filing ensures transparency regarding the promoter's shareholding status at the end of the fiscal year.

Promoter Dr. Harin Haridas Kanani created an encumbrance on 13,19,083 equity shares.
The pledge was created on March 30, 2026, just before the financial year-end.
Disclosure confirms no other promoter or PAC created, invoked, or released pledges in FY 2025-26.
The filing was submitted in compliance with Regulation 31(4) of SEBI Takeover Regulations.

💡 Investors should monitor the total percentage of promoter holding pledged to evaluate potential margin call risks. It is important to verify if the pledge was for personal liquidity or to support company growth initiatives.

Neogen Chemicals Shareholders Approve Preferential Issue to Promoters with 99.99% Majority

🟢 POSITIVE ⭐ 7/10

FUNDRAISE 📅 30 Mar 2026, 06:09 PM

Neogen Chemicals Limited has received overwhelming shareholder approval for the issuance of equity shares on a preferential basis to a member of the promoter group. During the Extraordinary General Meeting (EGM) held on March 29, 2026, the special resolution was passed with 99.9999% of the votes in favor. A total of 2,04,17,139 valid votes were cast, with only 20 votes against the proposal. This capital infusion from the promoters is expected to strengthen the company's financial position and signals strong promoter confidence.

Special resolution for preferential issuance of equity shares to the Promoter group was approved.
The resolution received 2,04,17,119 votes in favor, accounting for 99.9999% of total valid votes.
Only 20 votes (0.0001%) were cast against the proposal during the voting process.
The EGM was conducted via Video Conferencing with remote e-voting held between March 26 and March 28, 2026.
The Scrutinizer's report confirmed the resolution was passed with the requisite majority as a Special Resolution.

💡 Investors should take this as a positive sign of promoter commitment and financial support for the company's growth plans. Monitor for further disclosures regarding the specific allotment price and the intended use of the raised capital.

Neogen Chemicals EGM Approves Preferential Equity Issue to Promoter Group

🟢 POSITIVE ⭐ 7/10

FUNDRAISE 📅 29 Mar 2026, 04:21 PM

Neogen Chemicals Limited held an Extraordinary General Meeting (EGM) on March 29, 2026, to seek shareholder approval for a preferential issue of equity shares to its promoter group. During the meeting, management addressed shareholder queries regarding the utilization of proceeds and the impact of current geopolitical situations on the company. The resolution was proposed as a Special Resolution, indicating a significant corporate action to raise capital from internal stakeholders. Final voting results and the specific quantum of the fundraise are expected to be disclosed within 48 hours.

Special Resolution proposed for the issuance of equity shares on a preferential basis to the Promoter group.
Management clarified the object of the issue and the planned utilization of proceeds during the meeting.
The EGM was held on March 29, 2026, and concluded with a facility for electronic voting for all members.
The company addressed concerns regarding foreign investor shareholding and current geopolitical impacts.
Final scrutinizer's report and voting results to be released within 48 hours of the meeting conclusion.

💡 Investors should monitor the upcoming disclosure for the specific issue price and total amount being raised, as promoter participation typically signals long-term confidence.

Neogen Chemicals Announces Trading Window Closure from April 1, 2026

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 27 Mar 2026, 07:21 PM

Neogen Chemicals Limited has informed the exchanges that its trading window will be closed starting April 1, 2026, for all designated persons and their relatives. This closure is in compliance with SEBI Insider Trading regulations ahead of the declaration of audited financial results for the quarter and year ending March 31, 2026. The window will remain shut until 48 hours after the financial results are officially announced. The specific date for the board meeting to approve these results will be communicated separately in the future.

Trading window closure effective from April 1, 2026, for all designated persons.
Closure pertains to the Audited standalone and consolidated financial results for Q4 and FY26.
The window will reopen 48 hours after the results are declared to the public.
Board meeting date for financial result approval is yet to be determined and announced.

💡 This is a standard regulatory filing with no direct impact on company fundamentals; investors should wait for the upcoming earnings announcement for performance updates.

Neogen Chemicals to Raise Rs 161 Crore via Preferential Issue for Battery Materials Expansion

🟢 POSITIVE ⭐ 8/10

FUNDRAISE 📅 17 Mar 2026, 05:31 PM

Neogen Chemicals is proceeding with a preferential issue of 10,00,000 equity shares to a promoter group entity, Cadamba Solutions, at a price of Rs 1,610 per share, which is a premium over the floor price. The total fundraise of approximately Rs 161 crore will primarily fund the company's entry into the battery chemicals space through its subsidiary, Neogen Ionics Limited. A significant portion of Rs 100 crore is earmarked for a large-scale greenfield project in Gujarat with a total estimated capex of Rs 1,500 crore. This project targets the Lithium-Ion battery market and is expected to generate peak revenues between Rs 2,500 crore and Rs 2,950 crore.

Preferential allotment of 10 lakh shares to promoter group at Rs 1,610 per share, totaling Rs 161 crore.
Rs 100 crore allocated for investment in Neogen Ionics Limited for battery chemical manufacturing facilities.
Total project capex estimated at Rs 1,500 crore with a peak revenue potential of Rs 2,500-2,950 crore.
Expansion includes 30,000 MTA Electrolyte capacity and 5,500 MTA Specialty Lithium Salts/Additives capacity.
Funds to be utilized within 90 days of allotment for expansion, working capital (Rs 21 cr), and general purposes (Rs 40 cr).

💡 Investors should monitor the execution of the high-value battery materials project as it represents a significant strategic pivot. The promoter's capital infusion at a premium to the floor price is a strong signal of confidence in the company's long-term growth prospects.

Neogen Chemicals Details ₹161 Cr Preferential Issue & ₹1,500 Cr Battery Materials Capex

🟢 POSITIVE ⭐ 8/10

FUNDRAISE 📅 17 Mar 2026, 05:28 PM

Neogen Chemicals is issuing 10 lakh equity shares to a promoter group entity at ₹1,610 per share, which is a premium over the floor price of ₹1,375.82. The proceeds of approximately ₹161 crores will be used to fund the company's entry into the battery materials segment via its subsidiary, Neogen Ionics. The company has outlined a massive ₹1,500 crore capex plan for its Gujarat facilities, targeting a peak revenue potential of ₹2,500-₹2,950 crores. This strategic pivot focuses on the high-growth Lithium-Ion battery material space.

Preferential allotment of 10,00,000 equity shares to promoter group entity Cadamba Solutions at ₹1,610 per share.
₹100 crore of the proceeds to be invested in subsidiary Neogen Ionics for battery material projects within 90 days.
Total project capex at Pakhajan and Dahej sites estimated at ₹1,500 crore with peak revenue potential of ₹2,500-₹2,950 crore.
Planned capacity includes 30,000 MTA of Electrolyte and 3,000 MTA of Specialty Lithium Electrolyte Salts.
Clarification on inter-se promoter transfers of ~52.76 lakh shares to family trusts for internal reorganization.

💡 The promoter's decision to subscribe to shares at a premium indicates strong internal confidence in the new battery materials vertical. Investors should monitor the execution timelines of the ₹1,500 crore capex as it is the primary driver for future growth.

Neogen Chemicals to Raise Rs 161 Crore via Preferential Issue to Promoter Group

🟢 POSITIVE ⭐ 8/10

FUNDRAISE 📅 07 Mar 2026, 04:08 PM

Neogen Chemicals' board has approved the issuance of 10 lakh equity shares at a price of Rs 1,610 per share, totaling Rs 161 crore. The shares are being issued on a preferential basis to Cadamba Solutions Private Limited, a promoter group entity. This issue price represents a significant 17.02% premium over the regulatory floor price of Rs 1,375.82. An Extraordinary General Meeting (EGM) is scheduled for March 29, 2026, to seek shareholder approval for this capital infusion.

Issuance of 1,000,000 equity shares at Rs 1,610 each, aggregating to Rs 161 crore
The issue price is 17.02% higher than the SEBI-calculated floor price of Rs 1,375.82
The entire allotment is directed to Cadamba Solutions Private Limited, part of the promoter group
Post-allotment, the allottee will hold a 3.65% stake in the company
Extraordinary General Meeting (EGM) set for March 29, 2026, with a record date of March 20, 2026

💡 Investors should view this as a positive signal as the promoters are increasing their stake at a significant premium to the floor price. Monitor the company's subsequent announcements regarding the specific utilization of these funds for growth or debt reduction.

Neogen Chemicals to Raise Rs 161 Crore via Preferential Issue to Promoters

🟢 POSITIVE ⭐ 7/10

FUNDRAISE 📅 07 Mar 2026, 03:57 PM

Neogen Chemicals has announced an Extra Ordinary General Meeting (EGM) on March 29, 2026, to seek approval for a preferential issue of equity shares. The company plans to issue 10,00,000 shares to Cadamba Solutions Private Limited, a promoter group entity, at a price of Rs. 1,610 per share. This transaction will result in a total capital infusion of Rs. 161 crores into the company. The relevant date for determining the floor price was set as February 27, 2026, and the cut-off date for voting eligibility is March 20, 2026.

Preferential allotment of 10,00,000 equity shares to promoter group entity Cadamba Solutions Private Limited.
Issue price fixed at Rs. 1,610 per share, including a premium of Rs. 1,600 per share.
Total fundraise amount of Rs. 161 crores to be received as 100% cash consideration.
EGM scheduled for March 29, 2026, with remote e-voting available from March 26 to March 28, 2026.
The capital infusion is subject to SEBI and stock exchange approvals following recent inter-se promoter transfers.

💡 Investors should view this promoter-led capital infusion as a strong signal of confidence in the company's long-term growth. The non-debt funding will strengthen the balance sheet and support future expansion plans.

Neogen Chemicals to Raise ₹161 Crore via Preferential Issue to Promoter Group

🟢 POSITIVE ⭐ 8/10

FUNDRAISE 📅 07 Mar 2026, 03:47 PM

Neogen Chemicals has convened an Extra Ordinary General Meeting (EGM) on March 29, 2026, to approve a preferential issue of equity shares. The company intends to issue 10,00,000 shares to Cadamba Solutions Private Limited, a member of the promoter group. The shares are priced at ₹1,610 each, including a premium of ₹1,600, resulting in a total fund infusion of ₹161 crore. This capital injection by the promoters indicates strong internal confidence in the company's future growth prospects.

Issuance of 10,00,000 equity shares at a fixed price of ₹1,610 per share.
Total capital raise amounting to ₹161 crore from promoter group entity Cadamba Solutions Private Limited.
Relevant date for floor price determination set as February 27, 2026, in accordance with SEBI ICDR regulations.
EGM scheduled for March 29, 2026, to seek shareholder approval via special resolution.
The allotment is subject to a lock-in period as per SEBI regulations and requires specific regulatory exemptions due to prior inter-se transfers.

💡 Investors should view the promoter's capital infusion at a significant premium as a positive signal of long-term commitment. Monitor the EGM results and subsequent disclosures regarding the specific utilization of these funds for expansion or debt reduction.

Neogen Chemicals to Raise Rs 161 Crore via Preferential Issue to Promoter Group

🟢 POSITIVE ⭐ 7/10

FUNDRAISE 📅 07 Mar 2026, 02:09 PM

Neogen Chemicals' board has approved the issuance of 10 lakh equity shares at a price of Rs 1,610 per share, aggregating to Rs 161 crore. The shares are being issued to Cadamba Solutions Private Limited, a promoter group entity, which will hold a 3.65% stake post-allotment. Significantly, the issue price is at a 17.02% premium over the regulatory floor price of Rs 1,375.82. An Extra Ordinary General Meeting (EGM) is scheduled for March 29, 2026, to obtain shareholder approval for the transaction.

Issuance of 10,00,000 equity shares at Rs 1,610 per share, totaling Rs 161 crore
Issue price is 17.02% higher than the SEBI-mandated floor price of Rs 1,375.82
Allottee is Cadamba Solutions Private Limited, a member of the promoter group
Post-allotment, the allottee will hold a 3.65% stake in the company
EGM for shareholder approval is set for March 29, 2026, with a record date of March 20, 2026

💡 Investors should take confidence from the promoter group's decision to infuse capital at a significant premium to the floor price. This move strengthens the balance sheet and indicates strong internal backing for the company's growth prospects.

View All NEOGEN Announcements on Live Market Tracking →

💰 Financial Performance

Revenue Growth by Segment

Consolidated revenue grew 13% YoY to INR 777.6 Cr in FY25, driven by healthy volumes in the base business and BuLi Chem. Neogen Ionics contributed INR 12 Cr in its first year. Standalone revenue rose 10% to INR 773.7 Cr. However, Q2 FY26 consolidated revenue growth slowed to 8% (INR 208.7 Cr) due to the temporary suspension of the Dahej plant.

Geographic Revenue Split

Not explicitly disclosed in percentages, but the company reports a global distribution network supporting export growth and is strategically diversifying into stable geographies to mitigate regional economic downturns.

Profitability Margins

FY25 Standalone PAT margin improved to 6.26% from 5.86% (a 7% increase). Consolidated PAT for Q2 FY26 dropped 69% YoY to INR 3.4 Cr, with PAT margins contracting by 405 bps to 1.6% due to elevated operating costs and interest expenses following the Dahej fire incident.

EBITDA Margin

FY25 Standalone EBITDA margin grew 240 bps to 19.0% (INR 147.1 Cr). In Q2 FY26, consolidated EBITDA margins fell 349 bps to 14.4% (INR 30.0 Cr) due to higher insurance premiums, increased job work costs, and performance-linked employee incentives.

Capital Expenditure

Neogen recently raised INR 253 Cr to fund large-scale capex. Ongoing investments include the organic Dahej SEZ plant rebuild and battery business expansion. The company is also utilizing INR 200 Cr from NCDs and INR 65 Cr in unsecured loans to support these initiatives.

Credit Rating & Borrowing

CRISIL maintains a 'Negative' outlook due to liquidity pressure. Standalone debt rose sharply to INR 722 Cr in Q2 FY26 (Net Debt INR 595 Cr). Interest coverage stood at 2.56x in FY25 but faced pressure in Q2 FY26 as interest costs rose 53% YoY to INR 19.5 Cr.

⚙️ Operational Drivers

Raw Materials

Key materials include Lithium salts, Bromine, and various chemical intermediates. While specific % of total cost per material is not disclosed, raw material price fluctuations and oversupply-led weak pricing significantly impacted FY25 margins.

Import Sources

Sourced from multiple suppliers across different global regions to ensure supply chain resilience; specific countries are not listed but the strategy emphasizes vendor diversification.

Key Suppliers

Not disclosed by name; however, the company utilizes a procurement team to manage long-term relationships with multiple regional suppliers to secure cost-effective materials.

Capacity Expansion

Current operations include plants at Mahape (Navi Mumbai), Karakhadi (Vadodara), and Dahej. The Dahej SEZ organic plant is undergoing a rebuild following a fire, with resumption planned for FY27. Future revenue targets of INR 950-1,000 Cr are based on current installed capacity.

Raw Material Costs

Inventory turnover improved 22% to 2.25 in FY25, indicating better material movement. Procurement strategies focus on maintaining adequate inventory levels to hedge against price volatility in chemical intermediates.

Manufacturing Efficiency

Operating leverage from higher volumes contributed to a 27% EBITDA growth in FY25. Manufacturing efficiency is supported by R&D-led process improvements and strategic job work to maintain volumes during plant outages.

Logistics & Distribution

Not disclosed as a specific percentage of revenue, but logistical disruptions are cited as a key business risk being monitored quarterly.

📈 Strategic Growth

Expected Growth Rate

10%

Growth Strategy

Neogen targets INR 1,150 Cr revenue by FY28 through a 'double-digit' growth trajectory. Strategy includes: 1) Expanding the battery chemicals business (Lithium salts/electrolytes), 2) Increasing focus on high-margin Pharmaceutical and Custom Manufacturing (CSM) segments to offset Agrochemical cyclicality, and 3) Leveraging the BuLi Chem integration for customer cross-selling.

Products & Services

Specialty chemicals, Lithium salts, Electrolytes for Lithium-ion batteries, Bromine-based compounds, and Inorganic chemicals used in Pharma and Agrochemicals.

Brand Portfolio

Neogen Chemicals, BuLi Chem, Neogen Ionics.

New Products/Services

Locally sourced electrolytes and lithium salts for the EV battery chain; expected to bolster the business risk profile as the battery business ramps up.

Market Expansion

Expansion into the Lithium-ion battery sector and deepening penetration in the Japanese market through Neogen Chemicals Japan Corporation.

Market Share & Ranking

Not disclosed in percentage, but described as having a 'first-mover advantage' in the Indian electrolyte and lithium salt manufacturing space.

Strategic Alliances

Joint Venture: Dhara Fine Chem Industries; Subsidiaries: Neogen Ionics Limited and Neogen Chemicals Japan Corporation Limited.

🌍 External Factors

Industry Trends

The industry is shifting toward Lithium-ion battery localization in India. Neogen is positioning itself as a key supplier of electrolytes to capture this growth, moving away from a heavy reliance on traditional Agrochemical cycles.

Competitive Landscape

Faces intense global competition, particularly from cheap imports that lead to price volatility.

Competitive Moat

Moat is built on: 1) Technical expertise in complex Bromine and Lithium chemistry, 2) Long-term R&D track record (20+ years), and 3) High switching costs in the CSM and Pharma segments due to rigorous quality approvals.

Macro Economic Sensitivity

Highly sensitive to global chemical pricing and demand; FY25 performance was impacted by sluggish global demand despite volume growth.

Consumer Behavior

Shift toward Electric Vehicles (EVs) is driving demand for Neogen's new battery chemical portfolio.

Geopolitical Risks

Geopolitical disruptions and policy changes in key markets are monitored quarterly; these factors currently impact supply chain costs and logistics.

⚖️ Regulatory & Governance

Industry Regulations

Adheres to IND AS accounting standards and stringent safety protocols for chemical manufacturing. Operations are subject to environmental and pollution control board norms.

Environmental Compliance

Maintains zero effluent discharge deviations and monitors compliance through daily checks and quarterly safety audits.

Taxation Policy Impact

Effective tax rate for FY25 was approximately 25% (INR 19.5 Cr PBT vs INR 5.8 Cr Tax in Standalone).

Legal Contingencies

Not disclosed in absolute INR values, but the company tracks litigations through weekly compliance checklists and consults external legal experts for contract vetting.

⚠️ Risk Analysis

Key Uncertainties

1) Fire and operational accidents (Dahej incident caused INR 14.1 Cr loss), 2) Volatility in Lithium prices impacting battery segment margins, 3) Elongated working capital cycles.